Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microlyze was an environmental health and diagnostics company that developed proprietary sensor technology for real-time water quality monitoring. The company's primary innovation was a low-cost, high-precision sensor capable of detecting lead and other heavy metal contaminants in drinking water at the point of use. By integrating microfluidics and electrochemical sensing, Microlyze aimed to provide lab-grade results instantly, bypassing the need for traditional, time-consuming laboratory analysis. The technology was designed to empower households and municipalities to identify neurotoxic risks in their water infrastructure and prevent lead exposure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microlyze.